Predictors of Influenza-Associated Absenteeism and Impact of Vaccination in a Cohort of Guatemalan Agricultural Workers

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3K23AI143967-01S1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $49,756
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    DANIEL OLSON
  • Research Location

    United States of America
  • Lead Research Institution

    UNIVERSITY OF COLORADO DENVER
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease surveillance & mapping

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Farmers

Abstract

This is an Administrative Supplement Application to carry out SARS-CoV-2 PCR testing in an existing NIAID-funded study (1K23AI143967) evaluating the clinical and economic impacts of influenza in Guatemalanagricultural workers. The Parent Study includes the enrollment of an existing cohort (n=2,706) of Guatemalanagricultural workers with high rates of chronic medical conditions (CMCs) into a prospective active surveillancesystem for cough and fever (severe acute respiratory illness [SARI]). Workers meeting the case definition aretested for influenza A/B and RSV (Roche cobas® Liat RT-PCR Assay) and then clinical and economicoutcomes are assessed using follow up surveys and company reported absenteeism and productivity data. This Administrative Supplement will allow us to maintain our cough/fever surveillance system, given anincrease in expected cases due to SARS-CoV-2, and to perform RT-PCR testing for SARS-CoV-2. Wehypothesize that, similar to influenza, COVID-19 will place a significant clinical and economic burden onagricultural workers, especially the large proportion with CMCs, such as chronic kidney disease of unknownorigin (CKDu, aka "Mesoamerican nephropathy"), given existing data showing a significantly increased risk ofsevere disease. Evaluating these outcomes in an existing prospective cohort will allow us to measure theseburdens on a population-level, which will provide critical data in understanding the true impact of disease. Weaim to implement our SARS-CoV-2 testing immediately, analyze and disseminate our results quickly, andmake samples from our specimen biobank (annual blood and urine, acute illness respiratory and blood)available for additional research.